Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Dyadic International Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of DYAI: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3432−2
Shares3.74M4.49M+754.1K (+20.2%)
Value$7.14M$5.52M−$1.61M (−22.6%)

New holders (1)

Institutions that held Dyadic International Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to DYAI in Q4 2022
InstitutionSharesValue% of portfolio
Chapin Davis, Inc.819,629$1.01M0.59%

Sold out (3)

Institutions that held Dyadic International Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of DYAI in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Susquehanna International Group, LLP37,427$71.0K
Captrust Financial Advisors15,000$29.0K
Castle Wealth Management LLC3,500$7.00K